AASLD develops evidence-based practice guidelines and practice guidances which are updated regularly by a multi-disciplinary panel of experts.

These clinical practice guidelines will provide evidence-based advice for the assessment and management of patients with HCC.

The following Clinical Practice Guidelines will give up-to-date advice for the clinical management of patients with hepatocel- lular carcinoma, as well as ...

14 окт. 2024 г. · Guidelines for the screening, surveillance, diagnosis, and treatment of hepatocellular carcinoma (HCC) have been issued by the following organizations.

The 2018 ESMO Clinical Practice Guidelines on hepatocellular carcinoma (HCC) are conceived to provide the standard approach to diagnosis and local and systemic ...

Most Asia HCC practice guidelines recommend regular sur- veillance at six-month intervals for HCC in high-risk groups, including patients with chronic hepatitis ...

BSG guidelines for managing hepatocellular carcinoma (HCC), offering evidence-based advice for diagnosis, treatment, and patient management.

Hepatocellular Carcinoma · Guidelines · Evidence Blocks · Frameworks · Guidelines for Patients · International · Disclosures. Disclosure Policy · Panel Member ...

30 мая 2023 г. · Updated treatment recommendations for hepatocellular carcinoma (HCC) from the ESMO clinical practice guidelines. Ann Oncol. 2021; 32:801-805.

This guidance document provides an updated approach to the prevention, diagnosis, and treatment of hepatocellular carcinoma (HCC).